Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024
LONDON and SALT LAKE CITY, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled...
LONDON and SALT LAKE CITY, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled...
Amydis Novel Tracer Utilizes an Affordable, Accessible, Non-Invasive Approach as part of a Standard Office VisitSAN DIEGO, Nov. 14, 2023...
HALIFAX, NS, Nov. 13, 2023 /PRNewswire/ -- In a significant recognition of its pioneering work in medical technology, Sparrow Bioacoustics has been...
Nominates Didier Hirsch and Martin Madaus for election to the Board of Directors Upon the election of Messrs. Hirsch and Madaus, seven...
The Accure Laser System is the first 1726nm-based medical device platform in the world to achieve both FDA clearance and...
ANN ARBOR, MI / ACCESSWIRE / November 13, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary...
Long-term relationship will focus on the potential for new advancements to expand patient and clinician access and transform the approach...
PASADENA, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW),...
Results Suggest Formulation Potentially Suitable for At-Home Administration Ketabon Also Releases In-Depth Data from Phase 2 KET01 Trial MUNICH, Germany,...
IRVINE, Calif.--(BUSINESS WIRE)--Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment...
- Preclinical Orders for Additional Customers Underway -STONY BROOK, NY / ACCESSWIRE / November 9, 2023 / Applied DNA Sciences,...
SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents...
Collaboration to utilize cutting-edge AI analysis platform for clinical trials and cancer screening test processingBERKELEY, Calif. and MAINZ, Germany, Nov....
Company sees significant momentum in Pharmaloz, Nebula Genomics and ProPhase BioPharma Pharmaloz Manufacturing plans on track to increase capacity from...
Diagnostics laboratory supports pioneering at-home testing solution for digital health startupSKOKIE, IL / ACCESSWIRE / November 8, 2023 / Lifescan...
CHICAGO & IRVINE, Calif.--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) and Masimo (Nasdaq: MASI) today announced a joint agreement to integrate Masimo...
REDMOND, WA / ACCESSWIRE / November 8, 2023 / EchoNous, the company at the forefront of premium handheld point-of-care ultrasound...
Seer technology receives recognition for excellence in the field of proteomicsREDWOOD CITY, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Seer,...
Rolf A. Classon Joins Masimo’s Board of DirectorsIRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today that Rolf A. Classon has been...
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), a leader in artificial intelligence-driven precision cardiovascular medicine tests, and Family Medicine Specialists...